Literature DB >> 3121201

Malignant disease: nutritional implications of disease and treatment.

S Holmes1, J W Dickerson.   

Abstract

Protein-energy malnutrition (PEM) is common in cancer patients and may develop into the syndrome known as 'cancer cachexia'. This is characterised by complex disturbances in carbohydrate, lipid, protein, and electrolyte metabolism. The aetiology is equally complex, with host and therapeutic factors contributing to the reduced food intake and effects on host tissues. Anorexia is of prime importance, differing in its cause from one patient to another and often presenting a barrier to successful nutritional support. Further research is necessary to elucidate the interaction of central and peripheral factors that may be involved in the aetiology of anorexia. Because of the interplay of biochemical, physiological, and psychological consequences of cancer, the nutritional support of the patient presents a considerable challenge to the caring professions.

Entities:  

Mesh:

Year:  1987        PMID: 3121201     DOI: 10.1007/bf00144270

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  180 in total

1.  Systemic effects of tumors in force-fed rats. III. Effect on the composition of the carcass and liver and on the plasma lipids.

Authors:  A G STEWART; R W BEGG
Journal:  Cancer Res       Date:  1953-08       Impact factor: 12.701

Review 2.  Nutritional problems induced by cancer.

Authors:  M E Shils
Journal:  Med Clin North Am       Date:  1979-09       Impact factor: 5.456

Review 3.  Cancer cachexia.

Authors:  A Theologides
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

4.  Cachexia, gluconeogenesis and progressive weight loss in cancer patients.

Authors:  T P Stein
Journal:  J Theor Biol       Date:  1978-07-06       Impact factor: 2.691

5.  Vitamin A and lung cancer.

Authors:  C Mettlin; S Graham; M Swanson
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

6.  Uncomplicated starvation versus cancer cachexia.

Authors:  M F Brennan
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

7.  Importance of the colon in enteric hyperoxaluria.

Authors:  J W Dobbins; H J Binder
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

8.  Ascorbic acid supplementation and five year survival rates in women with early breast cancer.

Authors:  J M Poulter; W F White; J W Dickerson
Journal:  Acta Vitaminol Enzymol       Date:  1984

9.  Host-tumor interaction and nutrient supply.

Authors:  G P Buzby; J L Mullen; T P Stein; E E Miller; C L Hobbs; E F Rosato
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

10.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  5 in total

1.  Reliability of Untrained and Experienced Raters on FEES: Rating Overall Residue is a Simple Task.

Authors:  Jessica M Pisegna; James C Borders; Asako Kaneoka; Wendy J Coster; Rebecca Leonard; Susan E Langmore
Journal:  Dysphagia       Date:  2018-03-07       Impact factor: 3.438

2.  Food avoidance in patients undergoing cancer chemotherapy.

Authors:  S Holmes
Journal:  Support Care Cancer       Date:  1993-11       Impact factor: 3.603

3.  Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Zhen Chen; Yingjie Shao; Kun Wang; Wei Cao; Yulong Xiong; Rongzu Wu; Shicheng Luo; Xianlin Xu; Xiaozhou He
Journal:  Onco Targets Ther       Date:  2016-10-28       Impact factor: 4.147

4.  Standards, Options and Recommendations for the use of appetite stimulants in oncology (2000).

Authors:  J C Desport; G Gory-Delabaere; M P Blanc-Vincent; P Bachmann; J Béal; R Benamouzig; V Colomb; D Kere; J C Melchior; G Nitenberg; B Raynard; S Schneider; P Senesse
Journal:  Br J Cancer       Date:  2003-08       Impact factor: 7.640

5.  A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.

Authors:  S Downer; S Joel; A Allbright; H Plant; L Stubbs; D Talbot; M Slevin
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.